Dr. Lei Stanley Qi is an Assistant Professor of Bioengineering at the Stanford
University, United States. He is one pioneer for the development of the CRISPR/Cas
system for targeted gene regulation and chromosome imaging in mammalian cells.
His work has lead to a series of technologies, including CRISPR interference
(CRISPRi), CRISPR imaging, and high-throughput CRISPR screening. He obtained
his Ph.D. in Bioengineering from the University of California, Berkeley in 2012, and
performed independent research as a fellow in the University of California, San
Francisco 2012 - 2014. His lab is currently applying the CRISPR technologies for the
high-throughput interrogation of gene function related to cell differentiation,
proliferation and diseases in human cells.